31 search results for: disease control

ADVENT On Air | Early Intervention and <b>Disease</b> Modification in Atopic Dermatitis
Dermatology
ADVENT On Air | Early Intervention and Disease Modification in Atopic Dermatitis
Podcast

Prof. Thomas Bieber explores early intervention and disease modification in atopic dermatitis.

View more
Digestive <b>Disease</b> Week 2024 | Washington D.C.
Awareness Day
18
May
2024
Awareness Day
Digestive Disease Week 2024 | Washington D.C.

Join ADVENT at the Digestive Disease Week 2024 Congress and visit the Sanofi and Regeneron Medical Booth # 1707.

CLCI in Atopic Dermatitis Infographic
Dermatology
CLCI in Atopic Dermatitis Infographic
Infographic

This infographic highlights how uncontrolled moderate‑to‑severe atopic dermatitis (AD) can lead to Cumulative Life Course Impairment (CLCI) by contributing to ongoing physical, psychological, and social burdens such as itch and sleep loss, impaired bone growth and mental health challenges. It emphasizes the importance of early and effective disease control to help reduce long‑term impact on patients.

View more
Beyond Signs and Symptoms: Broadening Treatment Goals in Dermatology
Dermatology
Beyond Signs and Symptoms: Broadening Treatment Goals in Dermatology
expert video

Dr Lawrence Eichenfield explores the broadening of treatment goals for long-term disease control, highlighting the importance of this approach in atopic dermatitis. Drs Culton, Elmariah, and Hawkes expand the discussion to further examine specific management goals unique to each skin disease (bullous pemphigoid, prurigo nodularis, and chronic spontaneous urticaria).

View more
Giselle Mosnaim
Expert
Giselle Mosnaim, MD, MS, FAAAAI, FACAAI

Giselle Mosnaim is a board-certified allergist and immunologist at Endeavor Health and Clinical Assistant Professor at the University of Chicago Pritzker School of Medicine. An internationally recognized expert in asthma and allergic diseases, her clinical and research interests focus on severe and uncontrolled asthma, digital health, and improving patient outcomes through innovative, evidence-based care.

World Anosmia Day 2026
On Demand
World Anosmia Day 2026

Join the effort to improve CRSwNP care. World Anosmia Day serves as an opportunity to raise awareness about the loss of the sense of smell. Access some of countless educational resources with ADVENT below.

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma
Pulmonology
ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma
Podcast

Join Professors Klaus Rabe and Ian Pavord as they discuss the importance of on-treatment clinical remission as a goal in asthma management.

View more
ADVENT On Air | Exploring The Urgency to Treat in Atopic Dermatitis
Dermatology
ADVENT On Air | Exploring The Urgency to Treat in Atopic Dermatitis
Podcast

Professor Lisa Beck explores the chronic and persistent burden of atopic dermatitis (AD) as well as the concept of early intervention in patients with AD.

View more
Gap in Care Leads to Progression of Fibrosis in EoE
Gastroenterology
Gap in Care Leads to Progression of Fibrosis in EoE
expert video

Dr. Evan Dellon discusses the clinical implications of gaps in medical care on the risk of fibrotic progression in EoE.

View more
The Need for Maintenance Therapy in EoE
Gastroenterology
The Need for Maintenance Therapy in EoE
expert video

Hear Dr. Evan Dellon outline the benefits of maintenance therapy in EoE and the importance of an individualized treatment approach for each patient.

View more
Beyond Clinical <b>Control</b>: Targeting Type 2 Inflammation for Improved Patient Outcomes
Dermatology
Beyond Clinical Control: Targeting Type 2 Inflammation for Improved Patient Outcomes
expert video

Prof Alan Irvine presents the latest clinical and real-world evidence supporting the potential for disease modification in atopic dermatitis, at EADV 2025.

View more
Understanding Barriers to Advanced Systemic Therapy in AD
Dermatology
Understanding Barriers to Advanced Systemic Therapy in AD
expert video

Dr. Jean-David Bouaziz highlights a study describing barriers to initiating advanced systemic therapy for AD at EADV 2025

View more